High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Cerebras has the buzz, the OpenAI partnership, and the fastest inference chips in the market. Innodata has 12 straight quarters of growth, record profits, and a broadening customer base.
CBRS faces margin pressure and customer concentration, but strong RPO, expanding capacity and liquidity support its long-term growth outlook.
IPOs get plenty of press, and rightly so. They are the lifeblood of the markets, bringing new opportunities and new capital into the stock ecosystem. But IPOs also bring hard choices and counter-intuitive results, and those deserve a closer look. To start with, long-term analysis shows that most IPOs will actually underperform compared to their first day on the market. That first day benefits from high valuations and even higher levels of investor enthusiasm – but enthusiasm will wear off, and b
After losing half its value, is the AI computing specialist's stock finally cheap enough to buy?
One profitable hardware maker with a negative cash burn versus a hypergrowth cloud provider drowning in red ink, both betting on AI infrastructure dominance.
Cerebras Systems has seen its share price fall sharply so far in 2026, which puts a spotlight on whether the current valuation still lines up with what the balance sheet can support. With the stock under pressure, investors are increasingly asking how much today’s price rests on its book value rather than pure growth optimism. The share price is down 41.7% year to date, which makes the link between the current market value and Cerebras Systems' underlying net assets a much more pressing...
Investors were expecting an OpenAI IPO this year.
One is profitable with $510 million in revenue; the other burns cash but guards a battery moonshot.
Cerebras has grown revenue 2.5x over eight quarters, while BigBear.ai has stalled — a widening gap that signals very different competitive positions.
One operates in a crowded market and the other chases quantum's uncertain timeline.
Cerebras (CBRS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
One is consistently growing at high rates, while the other has shown inconsistent revenue performance.
Ark Invest added to three existing positions that are trading well below their recent highs.
Cathie Wood is buying the dip as Cerebras’ rapid AI growth faces growing questions over profitability.
Anthropic could see overwhelming demand and command a valuation near $2 trillion when it goes public, according to Connor Group founding executive Jim Neesen. "I expect Anthropic to be heavily oversubscribed at the time of IPO and well positioned to...
Cerebras' new CS-4 claims up to 30x faster token generation per user than GPU-based AI systems.
Cathie Wood just loaded up on three stocks, spanning different corners of the AI chip market.
The AI computing specialist's latest results were strong. The real story is a backlog worth almost 29 times this year's expected revenue.
Coatue Management’s Q2 filing disclosed a new position in Intel and, for the first time, a reportable position in newly public Cerebras. Coatue reported 12,084,027 Intel shares and roughly 7.01 million Cerebras shares at June 30. Intel Corporation (NASDAQ:INTC) offers manufacturing and established distribution, while Cerebras Systems Inc. (NASDAQ:CBRS) offers a radically different wafer-scale architecture. […]
Anthropic's unusual IPO plans could make one overlooked detail more important than the reported size of the offering.
Cerebras is adding another 165 MW of contracted AI data-center capacity as it races to convert its massive AI inference demand into physical infrastructure.
With global bond yields easing as inflation signals soften in the US, growth stocks are back in focus. Lower yield pressure can make the future earnings of fast growing companies look more attractive, especially when management has significant skin in the game through insider ownership. This article highlights three high growth, high insider commitment US stocks from our screener and explains why each one could deserve a closer look now. The three stocks covered below are just a starting...
NVIDIA is investing $3.5 billion in MediaTek and reviving the Rubin CPX chip program to defend against custom silicon rivals, backed by an $80 billion buyback and strong earnings growth.
Seven-year service orders support the phased Mikkeli build, which could bring up to €1.7 billion of regional investment and 250 permanent jobs.
Cerebras Systems (NasdaqGS: CBRS) introduced its CS-4 next generation AI accelerator for data center workloads. The company highlighted technical and economic advantages of the CS-4 compared with prior Cerebras hardware. Cerebras announced a partnership with Callosum focused on agentic inference workloads and scaling AI compute. This move by Cerebras Systems is part of a much wider build out in AI infrastructure, and there are many other stocks exposed to the same theme that you may want to...
Cerebras Systems stock has fallen sharply year to date, yet current valuation checks suggest the shares now look closer to fairly priced rather than clearly cheap or expensive. The share price is down 42.4% year to date, which pulls attention onto whether recent weakness has already adjusted expectations enough. The launch of the CS-4 accelerator and the new Callosum partnership can support higher growth expectations, while execution risk around scaling this AI hardware and software...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
